# ETFs That Hold Ascendis Pharma A/S (ASND)

> 61 thematic and core ETFs hold Ascendis Pharma A/S (ASND). MEDI holds the most, at 13.61% of the fund on Jul 31, 2026. Weights and dates for every holder.

Data as of Nov 5, 2026. Rebuilt every trading night.

## ETFs that hold Ascendis Pharma A/S

61 thematic and core ETFs hold Ascendis Pharma A/S , by holdings dated Jun 30, 2026 to Nov 3, 2026 . MEDI holds the most, at 13.61% of the fund on Jul 31, 2026 . The next largest are FPXE (6.06%) and AFOS (3.47%).

1 income and other fund on it is listed below.

### Thematic and core funds that hold it

| Fund | Name | Share of the fund | Holdings filed | Asset |
| --- | --- | --- | --- | --- |
| MEDI | Harbor Health Care ETF | 13.61% | Jul 31, 2026 | Equity |
| FPXE | First Trust IPOX Europe Equity Opportunities ETF | 6.06% | Nov 3, 2026 | Equity |
| AFOS | ARS Focused Opportunities Strategy ETF | 3.47% | Aug 31, 2026 | Equity |
| AADR | AdvisorShares Dorsey Wright ADR ETF | 3.19% | Jun 30, 2026 | Equity |
| FDG | American Century Focused Dynamic Growth ETF | 2.72% | Aug 31, 2026 | Equity |
| SQS | Sapient Quality Select ETF | 2.63% | Jul 31, 2026 | Equity |
| EXUS | Nomura Focused International Core ETF | 2.21% | Jun 30, 2026 | Equity |
| FMED | Fidelity Disruptive Medicine ETF | 1.97% | Aug 31, 2026 | Equity |
| TMED | T. Rowe Price Health Care ETF | 1.60% | Jun 30, 2026 | Equity |
| BBP | Virtus Biotech ETF | 1.54% | Jul 31, 2026 | Equity |
| FXH | First Trust Health Care AlphaDEX Fund | 1.38% | Nov 3, 2026 | Equity |
| TCAF | T. Rowe Price Capital Appreciation Equity ETF | 1.26% | Jun 30, 2026 | Equity |
| FFOG | Franklin Focused Growth ETF | 1.12% | Jun 30, 2026 | Equity |
| ILDR | First Trust Innovation Leaders ETF | 1.07% | Nov 3, 2026 | Equity |
| IBB | iShares Biotechnology ETF | 1.06% | Nov 3, 2026 | Equity |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.99% | Nov 3, 2026 | Equity |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 0.89% | Aug 31, 2026 | Equity |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 0.78% | Nov 3, 2026 | Equity |
| IWP | iShares Russell Mid-Cap Growth ETF | 0.38% | Nov 3, 2026 | Equity |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.35% | Jun 30, 2026 | Equity |
| WDAI | Pacer S&P World 3AI Top 300 ETF | 0.33% | Jul 31, 2026 | Equity |
| ESIM | Eventide International ETF | 0.29% | Jul 31, 2026 | Equity |
| IDHQ | Invesco S&P International Developed Quality ETF | 0.26% | Nov 3, 2026 | Equity |
| MSLC | Morgan Stanley Pathway Large Cap Equity ETF | 0.25% | Aug 31, 2026 | Equity |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.23% | Jun 30, 2026 | Equity |
| IYH | iShares U.S. Healthcare ETF | 0.19% | Nov 3, 2026 | Equity |
| SMMD | iShares Russell 2500 ETF | 0.19% | Nov 3, 2026 | Equity |
| QQHG | Invesco QQQ Hedged Advantage ETF | 0.15% | Nov 3, 2026 | Equity |
| RUSC | Russell Investments U.S. Small Cap Equity ETF | 0.12% | Jun 30, 2026 | Equity |
| REMC | Columbia Research Enhanced Mid Cap ETF | 0.12% | Jun 30, 2026 | Equity |
| IWR | iShares Russell Mid-Cap ETF | 0.10% | Nov 3, 2026 | Equity |
| EQAL | Invesco Russell 1000 Equal Weight ETF | 0.09% | Nov 3, 2026 | Equity |
| GSWO | Goldman Sachs ActiveBeta World Equity ETF | 0.09% | Aug 31, 2026 | Equity |
| IQSI | NYLIM Candriam International Equity ETF | 0.08% | Jul 31, 2026 | Equity |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.08% | Sep 30, 2026 | Equity |
| GSID | Goldman Sachs MarketBeta International Equity ETF | 0.06% | Aug 31, 2026 | Equity |
| MNZL | Manzil Russell Halal USA Broad Market ETF | 0.05% | Jul 31, 2026 | Equity |
| VDG | Vanguard Developed Markets ex-US Growth Index ETF | 0.05% | Sep 30, 2026 | Equity |
| BKIE | BNY Mellon International Equity ETF | 0.04% | Jul 31, 2026 | Equity |
| GGUS | Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF | 0.04% | Aug 31, 2026 | Equity |
| IWF | iShares Russell 1000 Growth ETF | 0.04% | Nov 3, 2026 | Equity |
| SPDW | State Street SPDR Portfolio Developed World ex-US ETF | 0.04% | Nov 3, 2026 | Equity |
| VDV | Vanguard Developed Markets ex-US Value Index ETF | 0.04% | Sep 30, 2026 | Equity |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.04% | Aug 31, 2026 | Equity |
| VONG | Vanguard Russell 1000 Growth ETF | 0.03% | Sep 30, 2026 | Equity |
| GXUS | Goldman Sachs MarketBeta Total International Equity ETF | 0.03% | Aug 31, 2026 | Equity |
| AVUQ | Avantis U.S. Quality ETF | 0.03% | Nov 2, 2026 | Equity |
| ONEO | State Street SPDR Russell 1000 Momentum Focus ETF | 0.03% | Nov 3, 2026 | Equity |
| IWB | iShares Russell 1000 ETF | 0.02% | Nov 3, 2026 | Equity |
| IWV | iShares Russell 3000 ETF | 0.02% | Nov 3, 2026 | Equity |
| RECS | Columbia Research Enhanced Core ETF | 0.02% | Jul 31, 2026 | Equity |
| VONE | Vanguard Russell 1000 ETF | 0.02% | Sep 30, 2026 | Equity |
| VTHR | Vanguard Russell 3000 ETF | 0.02% | Sep 30, 2026 | Equity |
| OMFL | Invesco Russell 1000 Dynamic Multifactor ETF | 0.01% | Nov 3, 2026 | Equity |
| VT | Vanguard Total World Stock Index ETF | 0.01% | Sep 30, 2026 | Equity |
| DEUS | Xtrackers Russell US Multifactor ETF | 0.01% | Aug 31, 2026 | Equity |
| IWS | iShares Russell Mid-Cap Value ETF | 0.01% | Nov 3, 2026 | Equity |
| FBCG | Fidelity Blue Chip Growth ETF | 0.01% | Jul 31, 2026 | Equity |
| REVS | Columbia Research Enhanced Value ETF | Ascendis Pharma A/S (ticker ASND, listed in DK) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.

Each row shows the date the fund last filed.

Look up another company .

### Questions people ask

Which ETFs hold Ascendis Pharma A/S? 61 thematic and core ETFs hold Ascendis Pharma A/S, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are MEDI at 13.61% of the fund on Jul 31, 2026, FPXE at 6.06% of the fund on Nov 3, 2026 and AFOS at 3.47% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart.

---

Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.
Cite: ETFIQ, ETFs holding ASCENDIS PHARMA A/S, data as of Nov 5, 2026. https://etfiq.com/holdings/asnd/
Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.
HTML: https://etfiq.com/holdings/asnd/